You test positive for COVID-19, ride it out at home, and think you're done. But what happens in the months that follow? A new study tracking over 3,000 adults who weren't hospitalized for COVID found that the story often continues in the doctor's office. In the six months after their diagnosis, 69% of these patients had at least one outpatient visit. About two-thirds of those visits were for a brand new health issue, and roughly a third involved seeing a specialist. Symptoms that could be tied to COVID, like ongoing fatigue or breathing problems, were common reasons for these appointments. While these visits tended to decrease after two months, for some people, they kept happening all the way through the four-to-six-month mark. This paints a picture of COVID's lingering footprint on people's health and the healthcare system. It's important to remember this was an observational study within one specific health network in Georgia. That means it can show a pattern of people seeking care, but it can't definitively say COVID caused all these new health issues. The findings highlight a real need for ongoing support, but more research is needed to understand the full, long-term picture.
Observational study tracks outpatient visits in nonhospitalized adult COVID-19 patientsWhat happens after a mild COVID case? Most people need follow-up care
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This observational study examined health care utilization and clinical characteristics 28-180 days after COVID-19 diagnosis in 3,171 nonhospitalized adult patients within an integrated health care system in Georgia. The study did not report a specific comparator group, primary outcome, or intervention beyond COVID-19 diagnosis.
The main results showed that 69% of patients had one or more outpatient visits during the 28-180 day follow-up period. Approximately two-thirds of patients had a visit for a new primary diagnosis, and about one-third had a new specialist visit. Symptoms potentially related to COVID-19 were common as new visit diagnoses, with visits for these symptoms decreasing after 60 days but continuing for some patients through 120-180 days. The study did not report specific effect sizes, absolute numbers, p-values, or confidence intervals for these findings.
Safety and tolerability data were not reported. The study has several important limitations: it is observational and can only show associations, not establish causality. The findings may not generalize beyond the specific health system and time period studied. No information was provided about funding or conflicts of interest. For clinical practice, these findings suggest that nonhospitalized COVID-19 patients frequently seek care for new symptoms in the months following diagnosis, but clinicians should interpret these patterns cautiously given the observational nature of the evidence.